Amlodipine: Can act as an antioxidant in patients with transfusion‐dependent β‐thalassemia? A double‐blind, controlled, crossover trial

BACKGROUND AND AIM: This study aimed to assess the antioxidant effects of amlodipine in transfusion‐dependent β‐thalassemia (TDT) patients. METHODS: This crossover trial consisted of two sequences (AP and PA). In the AP sequence, nine cases received amlodipine 5 mg daily (phase I) and then were swit...

Descripción completa

Detalles Bibliográficos
Autores principales: Darvishi‐Khezri, Hadi, Khalilzadeh Arjmandi, Hadiseh, Aliasgharian, Aily, Shaki, Fatemeh, Zahedi, Mohammad, Kosaryan, Mehrnoush, Karami, Hossein, Naeimayi Aali, Raheleh, Salehifar, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756999/
https://www.ncbi.nlm.nih.gov/pubmed/36357338
http://dx.doi.org/10.1002/jcla.24752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756999/
https://www.ncbi.nlm.nih.gov/pubmed/36357338
http://dx.doi.org/10.1002/jcla.24752

Ejemplares similares